Kirk et al. demonstrated in a prospective study in Gambia, a multiplicative effect on HCC risk resulting from HBV chronic infection and the mutational effect of AFB1 on the TP53 gene (codon 249). This evidence concerns the gene TP53 and hepatocellular carcinoma.